Cargando…

P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Piasecki, Julia, Desai, Keyur, Courtney, Carolyn, Thompson, Ethan, Pratt, James, Raje, Noopur, Patel, Krina, Raab, Marc S., Cook, Mark, Simonsen, Katy, Popa Mckiver, Mihaela, Kaiser, Shari, Martin, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430650/
http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75
_version_ 1785091017244934144
author Piasecki, Julia
Desai, Keyur
Courtney, Carolyn
Thompson, Ethan
Pratt, James
Raje, Noopur
Patel, Krina
Raab, Marc S.
Cook, Mark
Simonsen, Katy
Popa Mckiver, Mihaela
Kaiser, Shari
Martin, Nathan
author_facet Piasecki, Julia
Desai, Keyur
Courtney, Carolyn
Thompson, Ethan
Pratt, James
Raje, Noopur
Patel, Krina
Raab, Marc S.
Cook, Mark
Simonsen, Katy
Popa Mckiver, Mihaela
Kaiser, Shari
Martin, Nathan
author_sort Piasecki, Julia
collection PubMed
description
format Online
Article
Text
id pubmed-10430650
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306502023-08-17 P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA Piasecki, Julia Desai, Keyur Courtney, Carolyn Thompson, Ethan Pratt, James Raje, Noopur Patel, Krina Raab, Marc S. Cook, Mark Simonsen, Katy Popa Mckiver, Mihaela Kaiser, Shari Martin, Nathan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430650/ http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Piasecki, Julia
Desai, Keyur
Courtney, Carolyn
Thompson, Ethan
Pratt, James
Raje, Noopur
Patel, Krina
Raab, Marc S.
Cook, Mark
Simonsen, Katy
Popa Mckiver, Mihaela
Kaiser, Shari
Martin, Nathan
P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title_full P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title_fullStr P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title_short P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
title_sort p801: baseline and early post-infusion biomarkers associated with optimal response to idecabtagene vicleucel (ide-cel) in the karmma-3 study of triple-class–exposed relapsed and refractory multiple myeloma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430650/
http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75
work_keys_str_mv AT piaseckijulia p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT desaikeyur p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT courtneycarolyn p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT thompsonethan p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT prattjames p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT rajenoopur p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT patelkrina p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT raabmarcs p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT cookmark p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT simonsenkaty p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT popamckivermihaela p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT kaisershari p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma
AT martinnathan p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma